| Name | Title | Contact Details |
|---|
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve Respiratory Rhythm Management and cardiovascular health. The remedē® System is an innovative implantable stimulation device designed to restore natural breathing during sleep for patients with Central Sleep Apnea.
OrthoCare Orthotics and Prosthetics is a Leesburg, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
QMES, LLC is a rapidly growing Durable Medical Equipment (DME) company. We provide superior customer service 24-hours a day to clients located in nine states in the northeast region of the U.S.
Chase Ergonomics Inc. is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea.